NCT05611632 2026-04-14
NHS-Galleri
GRAIL, Inc.
Phase NA Active not recruiting
Clinical Trials
36 trialsNCT05155605 2026-04-13
PATHFINDER 2: A Multi-Cancer Early Detection Study
GRAIL, Inc.
Phase NA Active not recruiting
NCT05781555 2026-04-06
Alpha Radiation Emitters Device (DaRT) for Target Treatments of Malignant Tumors
Alpha Tau Medical LTD.
Phase NA Recruiting
NCT06340815 2026-03-06
Varian ProBeam Proton Therapy System Clinical Trial (Shandong)
Varian, a Siemens Healthineers Company
Phase NA Completed
NCT06564233 2026-03-06
Supportive Care Intervention for Outpatient Stem Cell Transplant Patients
Friendi.fi Corporation
Phase NA Recruiting
NCT05673018 2026-02-10
Galleri® in the Medicare Population.
GRAIL, Inc.
Phase NA Recruiting
NCT06347731 2025-12-15
Varian ProBeam360° Proton Therapy System China Clinical Trial (Wuhan)
Varian, a Siemens Healthineers Company
Phase NA Completed
NCT04875871 2025-05-11
PARTICLE-PATHY
EBG MedAustron GmbH
Phase NA Terminated
NCT06883058 2025-03-19
CASA pre-pilot
Ponce Medical School Foundation, Inc.
Phase NA Not yet recruiting
NCT05411848 2025-02-26
2kcal Tube Feed Study
Nutricia UK Ltd
Phase NA Completed
NCT04909034 2024-12-18
A Randomized, Placebo Controlled Study to Evaluate the Safety and Potential Efficacy of MS-20 in Combination with Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Microbio Co Ltd
Phase NA Completed
NCT05463055 2024-11-15
ProBeam
Varian, a Siemens Healthineers Company
Phase NA Completed
NCT06495528 2024-07-10
EPATPAC
Butterfly Therapeutics
Phase NA Recruiting
NCT06338436 2024-04-02
Varian ProBeam Proton Therapy System China Clinical Trial (Guangzhou)
Varian, a Siemens Healthineers Company
Phase NA Completed
NCT05133128 2024-02-22
IMMUNOPBMC
Servier
Phase NA Terminated
NCT05860530 2023-06-01
Bioequivalence Study of Two Olaparib Tablets in Patients With Cancers
Qilu Pharmaceutical Co., Ltd.
Phase NA Completed
NCT03000998 2023-02-06
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
Klein Buendel, Inc.
Phase NA Completed
NCT04241796 2022-10-25
Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical Practice
GRAIL, Inc.
Phase NA Completed
NCT04857008 2022-10-20
BNT001 Digital Therapeutic Feasibility Pilot Study
Blue Note Therapeutics
Phase NA Terminated
NCT05459168 2022-07-14
Development of Calm for Cancer Prototype Mobile App
Calm.com, Inc.
Phase NA Completed
NCT05227534 2022-07-06
PREVENT
Guangzhou Burning Rock Dx Co., Ltd.
Phase NA Recruiting
NCT05122715 2022-05-23
Demonstration Of A Next Generation PET CT System
GE Healthcare
Phase NA Unknown
NCT04548960 2021-09-09
OncoSNIPE
Oncodesign SA
Phase NA Unknown
NCT01436669 2021-03-18
Study of Home Full Blood Count (FBC) Telemonitoring Device for Chemotherapy Patient
Philips Healthcare
Phase NA Completed
NCT01478438 2021-03-03
A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers
Novian Health Inc.
Phase NA Unknown
NCT01413386 2020-03-11
MIRAII
Taewoong Medical Co., Ltd.
Phase NA Terminated
NCT01512563 2020-03-11
MIRA-cover
Taewoong Medical Co., Ltd.
Phase NA Completed
NCT03304145 2020-02-25
Shared Decision Making in Pain Management Planning in Patients With Cancer
Carevive Systems, Inc.
Phase NA Completed
NCT04086251 2019-09-11
Remote Electronic Patient Monitoring in Oncology Patients
Gaido Health
Phase NA Unknown
NCT03229772 2017-07-26
Demonstration of the "SPECT/CT System With CZT Detectors" Imaging Performance in a Clinical Setting
GE Healthcare
Phase NA Completed
NCT03198312 2017-06-26
CathiportTM Clinical Efficacy and Safety Evaluation
Shandong Branden Med.Device Co.,Ltd
Phase NA Unknown
NCT02167438 2017-03-22
Reducing Cesarean Childbirth Rates Using the Hem-Avert Perianal Stabilizer
Stetrix, Inc.
Phase NA Terminated
NCT02390986 2015-03-18
An Extension Study of LON002 in Patients With Cancer
LondonPharma Ltd.
Phase NA Unknown
NCT00923728 2014-01-10
A Phase I Trial of AVN944, an IMPDH Inhibitor, in Adults With Advanced Stage Solid Tumors
Vertex Pharmaceuticals Incorporated
Phase NA Withdrawn
NCT00443534 2013-05-24
A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.
Pfizer
Phase NA Completed
NCT01025167 2010-08-20
The Effect of a New Specific Enteral Formula Compared to a Standard Formula on the Tolerability of a Combined Radio- and Chemotherapy in Cancer Patients
Fresenius Kabi
Phase NA Completed